Evidence map›Paper›PMID 35332302›Full record

ArticleBone marrow transplantation2022

Quantile regression for censored data in haematopoietic cell transplant research.

Bo Wei

Abstract readEditorial
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bo WeiDepartment of Statistics, University of Michigan, Ann Arbor, MI, USA. boweinju@umich.edu.ORCID http://orcid.org/0000-0002-4335-5907

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

SERIES EDITORS' NOTE: One of the most important endpoints in haematopoietic cell transplant research is survival. A common objective is to interrogate which, if any, co-variates correlate with these endpoints. The most common statistical approach uses the Cox proportional hazards model. However, there are several problems and limitations of using this model including assumptions of proportional hazards and homogenous effects. In contrast, results of transplant studies often show non-proportional hazards because of early transplant-related mortality such that there is a survival disadvantage to transplants early on followed by a benefit. Even when a transplant proves better than a comparator not all transplant recipients benefit equally and some may be disadvantaged. Also, the favourable or unfavourable impact of a co-variate may vary in different time intervals. The accelerated failure time model which directly evaluates the association between survival and co-variates has similar limitations. Also, these models confer only a static view of the treatment effect. Several articles in our statistics series such as that by Zhen-Huan Hu and us (Bone Marrow Transplant. 2021 Aug 19. doi: 10.1038/s41409-021-01435-2), by Zhen-Huan Hu, Hai-Lin Wang and us and forthcoming articles by Megan Othus and by Liesbeth C. de Wreede, Johannes Schetelig and Hein Putter discuss issues in proper analyses of survival data from transplant studies including observational databases and randomized controlled trials. Are there better alternatives? A new popular model is quantile regression. In this typescript Bo Wei concisely introduce the quantile regression model for right censored data. He uses data from a Center for International Blood and Marrow Transplant Research (CIBMTR) registry study to show how to use the quantile regression and interpret the results. He also discusses use of quantile regression in complex survival analyses such as competing risk data or non-compliant data. Quantile regression is a natural, powerful approach for analyzing censored data with heterogenous co-variate effects. It has advantages compared with other survival models in depicting the dynamic association between survival outcome and co-variates. It can be applied to other transplant outcomes such as cumulative incidence of relapse, event-free and relapse-free survivals. There is an equation, but only one. Remember: The only thing to fear is fear itself (FDR). Please stick with it and you will be rewarded.Robert Peter Gale MD, PhD, DSc(hc), FACP, FRCP, FRCPI(hon), LHD, DPS, Mei-Jie Zhang PhD.

Indexed as

Hematopoietic Stem Cell TransplantationBone Marrow TransplantationHumansIncidenceMaleProportional Hazards ModelsSurvival Analysis

Identifiers

PMID35332302
PMCPMC13335609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.